Donald Mattison

Health Sciences Distinguished Professor

University of South Carolina

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Donald Mattison is a Health Sciences Distinguished Professor at the University of South Carolina. His research focuses on vaccine safety surveillance, biomarkers for manganese exposure, and adverse event reporting related to drug therapies. Recent articles authored by him encompass topics such as pharmacovigilance for respiratory syncytial virus vaccines and the assessment of neurological reactions to COVID-19 vaccines.

Articles (8)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (2)

Nicholas Birkett

Associate Professor

University of Ottawa Faculty of Medicine

CANADA

View details

Abdallah Alami

University of Ottawa

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Donald Mattison

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Safety surveillance of respiratory syncytial virus (RSV) vaccine among pregnant individuals: a real-world pharmacovigilance study using the Vaccine Adverse Event Reporting System

Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

Magnetic resonance imaging T1 indices of the brain as biomarkers of inhaled manganese exposure

Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system

Compounded bioidentical hormone products, a path forward

Biomarkers for occupational manganese exposure

Biomarkers of environmental manganese exposure

Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study

Collaborators (2)

Nicholas Birkett

Abdallah Alami

Make your next move.